Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.

Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

Scientists have witnessed the formation of the solid-electrolyte interphase, a critical component in lithium-ion batteries.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

Scientists have uncovered a root cause of the growth of needle-like structures—known as dendrites and whiskers—that plague lithium batteries, sometimes causing a short circuit, failure, or even a fire.

PNNL researchers have created a chemical cocktail that could help electric cars power their way through extreme temperatures where current lithium-ion batteries don’t operate as efficiently as needed.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.

PNNL researchers demonstrate how the excitation of oxygen atoms that contributes to better performance of a lithium-ion battery also triggers a process that leads to damage, explaining a phenomenon that has been a mystery to scientists.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

He is being recognized for his contributions involving various kinds of separations with mass spectrometry (MS).

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

The structure of a fundamental electrical switch in the brain has been revealed, thanks to PNNL researchers working together with counterparts at Oregon Health & Science University (OHSU).